Dr. Larry Schlesinger MD

Larry S. Schlesinger, MD is an internationally recognized authority in infectious diseases. He became Professor, President and CEO of Texas Biomedical Research Institute in San Antonio, TX in 2017 and is leading a transformational process focused on scientific growth and cultural change, a new campus master plan and new research and education programs. Since his arrival, Texas Biomed has added 16 new faculty members, raised more than $60 million through philanthropic efforts and other avenues for recruitment of scientists, new programs, and infrastructure needs. He has also overseen the restructuring of leadership and business practices leading to more than a doubling of grants and contracts at Texas Biomed in recent years.

Dr. Schlesinger is a leading physician scientist whose research program focuses on how the lung environment shapes alveolar macrophage biology in the context of tuberculosis and other airborne infections that subvert lung immune mechanisms. He is a prolific scholar, having authored more than 220 peer-reviewed articles and reviews, served as editor of 2 books and has written several chapters in leading textbooks (H index 78). He has been continually funded by the NIH and other federal agencies as well as private foundations such as the Bill & Melinda Gates Foundation for more than 30 years. He has trained ~ 170 individuals and led NIH-funded training programs. He is a recent NIH NIAID Council member, Fellow of the American Association for -the Advancement of Science, Infectious Diseases Society of America, Association of American Physicians and American Academy of Microbiology.​